These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 1344999
1. Immunological and beta-cell-specific characteristics of diabetes-prone BB/OK rats and their congenic derivatives--a comparative study. Schröder D, Klötting I, Hehmke B, Schmidt S. Diabetes Res; 1992; 20(1):21-31. PubMed ID: 1344999 [Abstract] [Full Text] [Related]
2. Occurrence of islet cell reactive autoantibodies in diabetes-prone BB/OK rats is not associated with the onset of diabetes: a cross-sectional study of BB rats and their diabetes-resistant congenic strains. Schlosser M, Ziegler B, Augstein P, Klöting I, Ziegler M. Diabetes Res; 1994; 26(2):67-77. PubMed ID: 7554727 [Abstract] [Full Text] [Related]
3. In vitro stimulation by islet antigen facilitates the detectability of beta-cell reactive cells in diabetes-prone BB/OK rats. Wanka H, Kuttler B, Knospe S, Hahn HJ. Autoimmunity; 1999; 30(4):223-34. PubMed ID: 10524498 [Abstract] [Full Text] [Related]
4. New congenic rat strains for the separate study of MHC and non-MHC genetic effects in the development of diabetes in BB rats. Kloeting I, Vogt L, Reetz IC, Wurst, Hedrich HJ, Guenther E. Diabetes Res; 1990 Sep; 15(1):41-5. PubMed ID: 1983425 [Abstract] [Full Text] [Related]
6. Congenic diabetes-prone BB.Sa and BB.Xs rats differ from their progenitor strain BB/OK in frequency and severity of insulin-dependent diabetes mellitus. van den Brandt J, Kovács P, Klöting I. Biochem Biophys Res Commun; 1999 Oct 05; 263(3):843-7. PubMed ID: 10512768 [Abstract] [Full Text] [Related]
7. Genes of SHR rats protect spontaneously diabetic BB/OK rats from diabetes: lessons from congenic BB.SHR rat strains. Klöting I, van den Brandt J, Kuttler B. Biochem Biophys Res Commun; 2001 May 04; 283(2):399-405. PubMed ID: 11327715 [Abstract] [Full Text] [Related]
8. Detection and time course of humoral-mediated cytotoxicity to different cell types in diabetes-prone BB/OK rats. Schröder D, Hehmke B, Klöting I, Schmidt S. Diabetes Res; 1991 Jun 04; 17(2):81-91. PubMed ID: 1817815 [Abstract] [Full Text] [Related]
9. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Satoh J, Shintani S, Oya K, Tanaka S, Nobunaga T, Toyota T, Goto Y. Diabetes; 1988 Sep 04; 37(9):1188-94. PubMed ID: 3044884 [Abstract] [Full Text] [Related]
10. Nitric oxide produced by macrophages mediates suppression of ConA-induced proliferative responses of splenic leukocytes in the diabetes-prone BB rat. Lee KU. Diabetes; 1994 Oct 04; 43(10):1218-20. PubMed ID: 7926291 [Abstract] [Full Text] [Related]
11. Prophylactic insulin treatment of diabetes-prone BB/OK rats by application of a sustained release insulin implant. Schröder D, Ratke M, Bauer UC, Klöting I, Ziegler B, Schmidt S. Autoimmunity; 2002 Mar 04; 35(2):143-53. PubMed ID: 12071437 [Abstract] [Full Text] [Related]
12. Co-culture of pancreatic islets and allogeneic lymphocytes: alterations of responder and stimulator cells. Kuttler B, Wanka H, Hahn HJ. Transplantation; 1997 Aug 15; 64(3):480-9. PubMed ID: 9275116 [Abstract] [Full Text] [Related]